In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020
- PMID: 36336172
- DOI: 10.1016/j.jinf.2022.10.038
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020
Conflict of interest statement
Declaration of Competing Interest The authors report no conflicts of interest.
Comment on
-
Increase of multidrug-resistant bacteria after the COVID-19 pandemic in South Korea: Time-series analyses of a long-term multicenter cohort.J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.09.026. Epub 2022 Sep 30. J Infect. 2022. PMID: 36183907 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
